SUSD2-IL-2 receptor interaction hinders antitumoral CD8+ T-cell activity: Implications for cancer immunotherapy

Pilar M. Moreno-Sanchez; Andrea Scafidi; Ilaria Salvato

SUSD2-IL-2 receptor interaction hinders antitumoral CD8+ T-cell activity: Implications for cancer immunotherapy

Pilar M. Moreno-Sanchez, Andrea Scafidi, Ilaria Salvato^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Original language	English
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Early online date	4 Jul 2023
Publication status	E-pub ahead of print - 4 Jul 2023

Keywords

cancer immunotherapy
CAR T cells
CD8 T cells
IL-2
SUSD2

Cite this

@article{df3b6742dced45efbb76c995c4c03830,

title = "SUSD2-IL-2 receptor interaction hinders antitumoral CD8+ T-cell activity: Implications for cancer immunotherapy",

keywords = "cancer immunotherapy, CAR T cells, CD8 T cells, IL-2, SUSD2",

author = "Moreno-Sanchez, {Pilar M.} and Andrea Scafidi and Ilaria Salvato",

note = "Funding Information: We acknowledge the financial support of the Luxembourg Institute of Health. PMS is supported by the Luxembourg National Research Fund (FNR; PRIDE19/14254520/i2TRON), AS by the Action Lions “Vaincre le Cancer” and IS by the FNRS‐T{\'e}l{\'e}vie (GBModIMM/7.8513.18 and GBModIMM/7.6517.20). ",

year = "2023",

month = jul,

day = "4",

language = "English",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - SUSD2-IL-2 receptor interaction hinders antitumoral CD8+ T-cell activity

T2 - Implications for cancer immunotherapy

AU - Moreno-Sanchez, Pilar M.

AU - Scafidi, Andrea

AU - Salvato, Ilaria

N1 - Funding Information: We acknowledge the financial support of the Luxembourg Institute of Health. PMS is supported by the Luxembourg National Research Fund (FNR; PRIDE19/14254520/i2TRON), AS by the Action Lions “Vaincre le Cancer” and IS by the FNRS‐Télévie (GBModIMM/7.8513.18 and GBModIMM/7.6517.20).

PY - 2023/7/4

Y1 - 2023/7/4

KW - cancer immunotherapy

KW - CAR T cells

KW - CD8 T cells

KW - IL-2

KW - SUSD2

UR - http://www.scopus.com/inward/record.url?scp=85164328988&partnerID=8YFLogxK

UR - https://pubmed.ncbi.nlm.nih.gov/37401528

M3 - Comment/debate

C2 - 37401528

SN - 0105-4538

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

ER -

SUSD2-IL-2 receptor interaction hinders antitumoral CD8+ T-cell activity: Implications for cancer immunotherapy

Keywords

Other files and links

Cite this